Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting.
Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting.
复制标题
DOI:
10.1042/bj20101569
复制
发表时间:
2011-03-01
期刊:
影响因子:
--
通讯作者:
Lee AS
中科院分区:
文献类型:
--
作者:
Ni M;Zhang Y;Lee AS
GRP78 is traditionally regarded as a major endoplasmic reticulum (ER) chaperone facilitating protein folding and assembly, protein quality control, Ca2+ binding and regulating ER stress signaling. It is a potent anti-apoptotic protein and plays a critical role in tumor cell survival, tumor progression and angiogenesis, metastasis and resistance to therapy. Recent evidence shows that GRP78 can also exist outside the ER. The finding that GRP78 is present on the surface of cancer but not normal cells in vivo represents a paradigm shift on how GRP78 controls cell homeostasis and provides an opportunity for cancer specific targeting. Cell surface GRP78 has emerged as an important regulator of tumor cell signaling and viability as it forms complexes with a rapidly expanding repertoire of cell surface protein partners, regulating proliferation, PI3K/AKT signaling and cell viability. Evidence is also emerging that GRP78 serves as a receptor for viral entry into host cells. Additionally, a novel cytosolic form of GRP78 is discovered prominently in leukemia cells. These, coupled with report of nuclear and mitochondria localized form in GRP78, point to the previously unanticipated role of GRP78 beyond the ER that may be critical for cell viability and therapeutic targeting.